Overview

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand the utilization patterns of doripenem in Asia Pacific, including the profile of the patients treated with carbapenems.
Phase:
Phase 4
Details
Lead Sponsor:
Johnson & Johnson Pte Ltd
Collaborator:
Johnson & Johnson (Hong Kong) Ltd.
Treatments:
Doripenem